BeStock  
Stocks › Biotechnology › HALO

Halozyme Therapeutics HALO

US equityMarket cap rank #1380Biotechnology
$91.35 −$1.69 (-1.82%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $91.35 0.00%
Open$93.64
Prev close$93.04
Day range$90.79 – $93.64
Volume1.50M
Market cap$10.41B
P/E (TTM)22.8
Dividend yield–

HALO Stock News

Headlines matching Halozyme Therapeutics or the HALO ticker, most recent first.

  • Analysts' Top NA Picks: High Roller Technologies, Inc. (ROLR), Halozyme (HALO)TipRanks · 3 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Halozyme Therapeutics(HALO.US) With Buy Rating, Maintains Target Price $115Market news · 3 Sep 2026 · Direct mention
  • Form 144 | Halozyme Therapeutics(HALO.US) Director Proposes to Sell 3.64 Million in Common StocksMarket news · 17 Sep 2026 · Direct mention
  • Halozyme Therapeutics(HALO.US) Officer Sells US$6.44 Million in Common StockMarket news · 12 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Halozyme Therapeutics(HALO.US), With a Forecast Between $93 to $115Market news · 8 Aug 2026 · Direct mention
  • Halozyme Therapeutics(HALO.US) Officer Sells US$6.28 Million in Common StockMarket news · 20 Aug 2026 · Direct mention
  • RIMBACO: JOINT ANNOUNCEMENT1. CLOSE OF MANDATORY UNCONDITIONAL CASH OFFER BY CMB INTERNATIONAL CAPITAL LIMITED AND CEB INTERNATIONAL CAPITAL CORPORATION LIMITED FOR AND ON BEHALF OF AUREOLE HALO LIMITED TO ACQUIRE ALL THE ISSUED SHARES OF RIMBACO GROUP GLOBAL LIMITHKEX · 7 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Halozyme Therapeutics(HALO.US) With Buy Rating, Maintains Target Price $95Market news · 22 Jul 2026 · Direct mention
  • Wells Fargo Maintains Halozyme Therapeutics(HALO.US) With Hold Rating, Maintains Target Price $75Market news · 15 Jun 2026 · Direct mention
  • Goldman Sachs Maintains Halozyme Therapeutics(HALO.US) With Sell Rating, Raises Target Price to $57 PositiveMarket news · 15 Jun 2026 · Direct mention
  • Morgan Stanley Maintains Halozyme Therapeutics(HALO.US) With Buy Rating, Maintains Target Price $93Market news · 15 Jun 2026 · Direct mention
  • J.P. Morgan Sticks to Its Hold Rating for Halozyme (HALO)TipRanks · 20 May 2026 · Direct mention
  • China Resources Land Life (1209.HK): A leading operator of consumer‑focused HALO assets in China.Huatai Securities · 15 May 2026 · Direct mention
  • TD Cowen Maintains Halozyme Therapeutics(HALO.US) With Buy Rating, Maintains Target Price $96Market news · 12 May 2026 · Direct mention
  • Morgan Stanley Maintains Halozyme Therapeutics(HALO.US) With Buy Rating, Cuts Target Price to $66.41 NegativeMarket news · 12 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on HALO.

Sign in to join the discussion.

Scroll to Top